BR100 Increased By (1.42%)
BR30 Increased By (1.31%)
KSE100 Increased By (1.2%)
KSE30 Increased By (1.25%)
AGHA 7.84 Increased By ▲ 0.09 (1.16%)
BECO 5.24 Increased By ▲ 0.05 (0.96%)
BML 57.90 Decreased By ▼ -0.76 (-1.3%)
BOP 34.38 Increased By ▲ 0.69 (2.05%)
CNERGY 10.90 Increased By ▲ 0.29 (2.73%)
CSIL 5.45 Increased By ▲ 0.15 (2.83%)
FCCL 54.90 Increased By ▲ 1.16 (2.16%)
FFL 16.80 Increased By ▲ 0.34 (2.07%)
FNEL 1.25 Increased By ▲ 0.03 (2.46%)
KEL 7.43 Increased By ▲ 0.15 (2.06%)
KOSM 5.84 Increased By ▲ 0.20 (3.55%)
LOTCHEM 29.98 Increased By ▲ 0.33 (1.11%)
MLCF 96.64 Increased By ▲ 0.28 (0.29%)
NBP 205.86 Increased By ▲ 2.33 (1.14%)
NCPL 57.95 Increased By ▲ 1.10 (1.93%)
NPL 68.89 Increased By ▲ 1.58 (2.35%)
OGDC 321.00 Increased By ▲ 2.78 (0.87%)
PACE 10.89 Increased By ▲ 0.26 (2.45%)
PAEL 43.22 Increased By ▲ 1.45 (3.47%)
PIBTL 17.10 Increased By ▲ 0.29 (1.73%)
PPL 223.50 Increased By ▲ 3.33 (1.51%)
PRL 52.30 Increased By ▲ 3.25 (6.63%)
PTC 71.30 Increased By ▲ 1.29 (1.84%)
SSGC 29.67 Increased By ▲ 0.53 (1.82%)
TBL 9.92 Increased By ▲ 0.15 (1.54%)
TELE 8.97 Increased By ▲ 0.15 (1.7%)
TPL 17.83 Increased By ▲ 0.66 (3.84%)
TPLP 12.95 Increased By ▲ 0.44 (3.52%)
TREET 22.92 Increased By ▲ 0.33 (1.46%)
TRG 60.35 Increased By ▲ 0.13 (0.22%)
By

LONDON: Revenue at Europe’s largest companies is expected to have risen by just 0.9% in the fourth quarter, Refinitiv I/B/E/S data showed on Tuesday, down from 27.4% in the third quarter and the slowest growth rate since the fourth quarter of 2020.

Earnings for STOXX 600 companies are expected to have increased 9.5% in the fourth quarter, down from 10.7% a week ago, Refinitiv I/B/E/S said.

When results from the energy sector are excluded, Refinitiv I/B/E/S said earnings were expected to have increased by 4.6% and revenue by just 0.3% in the final three months of the year.

Europe’s earnings season kicks into gear next week, with 56 companies expected to announce their fourth quarter results, including Italian bank UniCredit, Irish airline Ryanair, and pharmaceutical companies GSK and Novartis.

Analysts said the upcoming earnings season will likely show whether the renewed optimism about the economy that has buoyed equities in recent weeks is grounded in reality. To date, eight companies in the benchmark index have reported earnings, with 25% exceeding analysts estimates, versus a typical quarter, when 53% beat estimates, Refinitiv I/B/E/S said.

Nine firms have reported revenue, with 77.8 percent beating expectations, compared to a typical quarter when 58 percent beat estimates.

Comments

Comments are closed for this article.